Also trades as: 1801.HK (HKSE) · $vol 173M
IVBXF Earnings
Innovent Biologics, Inc.
1W: +2.8%
1M: -0.3%
3M: +9.6%
YTD: +18.3%
1Y: +4.7%
3Y: +260.6%
5Y: +7.6%
$12.80
+0.29 (+2.33%)
Weekly Expected Move ±14.3%
$9
$11
$13
$15
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-25
EPS
¥0.10 (US$0.02)
▲ Beat +48.8%
Revenue
¥1.3B ($189M)
▼ Miss -3.2%
Estimate vs Actual
Earnings Surprise History
5/15
EPS Beats
7/15
Revenue Beats
33%
EPS Beat Rate
47%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2026-12-31 | ¥1.42 | ¥1.42 | — | ¥19,474,239,961 | ¥19,445,514,968 |
| 2026-10-02 | annual | 2030-12-31 | ¥7.50 | ¥7.49 | ▼ 0.01 | ¥40,945,857,839 | ¥40,885,461,669 |
| 2026-10-02 | annual | 2029-12-31 | ¥4.70 | ¥4.69 | ▼ 0.01 | ¥36,039,655,318 | ¥35,986,495,921 |
| 2026-10-02 | annual | 2028-12-31 | ¥3.02 | ¥3.02 | — | ¥28,768,540,547 | ¥28,726,106,227 |
| 2026-10-02 | annual | 2027-12-31 | ¥2.21 | ¥2.21 | — | ¥24,410,424,841 | ¥24,374,418,851 |
| 2026-10-01 | annual | 2030-12-31 | ¥7.49 | ¥7.50 | ▲ 0.01 | ¥40,899,188,072 | ¥40,945,857,839 |
| 2026-10-01 | annual | 2029-12-31 | ¥4.69 | ¥4.70 | ▲ 0.01 | ¥35,998,577,602 | ¥36,039,655,318 |
| 2026-10-01 | annual | 2027-12-31 | ¥2.21 | ¥2.21 | — | ¥24,382,602,031 | ¥24,410,424,841 |
| 2026-10-01 | annual | 2026-12-31 | ¥1.42 | ¥1.42 | — | ¥19,452,043,375 | ¥19,474,239,961 |
| 2026-10-01 | annual | 2028-12-31 | ¥3.02 | ¥3.02 | — | ¥28,735,750,390 | ¥28,768,540,547 |
| 2026-09-30 | annual | 2027-12-31 | ¥2.21 | ¥2.21 | — | ¥24,379,766,021 | ¥24,382,602,031 |
| 2026-09-30 | annual | 2026-12-31 | ¥1.43 | ¥1.42 | ▼ 0.01 | ¥19,427,181,596 | ¥19,452,043,375 |
| 2026-09-30 | annual | 2028-12-31 | ¥3.02 | ¥3.02 | — | ¥28,700,020,710 | ¥28,735,750,390 |
| 2026-09-30 | annual | 2030-12-31 | ¥7.48 | ¥7.49 | ▲ 0.01 | ¥40,855,263,585 | ¥40,899,188,072 |
| 2026-09-30 | annual | 2029-12-31 | ¥4.68 | ¥4.69 | ▲ 0.01 | ¥35,959,907,317 | ¥35,998,577,602 |
Earnings Call Transcripts
No transcripts available.